Tag: healthcare
All the articles with the tag "healthcare".
-
China’s Brain-Computer Interface Story Is Starting to Look Real
A look at why China’s 2026 brain-computer interface momentum feels different: clinical use cases are getting clearer, national media is treating it as a public issue, and the payment system is starting to prepare for real adoption.
-
China’s Semaglutide Patent Cliff: Why a Price War Looks Likely
Semaglutide’s China patent cliff meets a crowded biosimilar queue and VBP-style purchasing pressure—tempered only by the real cost floor of injection pens and sterile manufacturing.
-
When a Flu Shot Is Cheaper Than Milk Tea: China’s Vaccine Price War
From a 5.5-yuan flu shot in Beijing to HPV and PCV13, a look at how overcapacity, overlapping pipelines, and policy-driven tenders are reshaping China’s vaccine industry and what it signals for pharma and diagnostics more broadly.
-
When Imported Drugs Leave China: VBP, generics, and trust
Field notes on China's volume-based procurement (VBP), the recent wave of imported originator drugs withdrawing from the market, and what it might mean for patients, generics, and global pharma from a Japan–China IVD vantage point.